m89-Acute Calculous Chole Cystitis 1-2

Embed Size (px)

Citation preview

  • 7/29/2019 m89-Acute Calculous Chole Cystitis 1-2

    1/23

    REFERENCES

    STRAS BERG SM. ACUTE CALCULOUS CHOLECYSTITIS

    N ENGL J MED 2008; 358:2804-11

    HUFFMAN JL, SCHENKER S. ACUTE ACALCULOUS CHOLECYSTITIS:

    A REVIEW. CLIN GASTROENTEROL HEPATOL 2010; 8:15-22.

  • 7/29/2019 m89-Acute Calculous Chole Cystitis 1-2

    2/23

    A complication of Cholelithiasis

    20 millions in USA/year

    Most Gallstones Asymptomatic

    Biliary colic develops 1% to 4%

    Acute cholecystitis in 20% of these symptomatic patients

    60% women

    Older

    With/without previous attacks More frequent in men relative to its incidence and more severe

    DM

    90% of acute cholecystitis is associated with gallstones

  • 7/29/2019 m89-Acute Calculous Chole Cystitis 1-2

    3/23

  • 7/29/2019 m89-Acute Calculous Chole Cystitis 1-2

    4/23

  • 7/29/2019 m89-Acute Calculous Chole Cystitis 1-2

    5/23

  • 7/29/2019 m89-Acute Calculous Chole Cystitis 1-2

    6/23

    Figure 1. Ultrasonographic images of three Gallbladders.

    A normal, sonolucent gallbladder (panel A) is characterized

    by a thin wall and an absence of acoustic shadows. In a

    patient with symptomatic gallstones (panel B), the

    gallblader contains small echogenic objects with posterioracoustic ghadows that are typical of gallstones (arrow),

    with a normal wall thickness. In a patient with acute

    calculous cholecystitis (panel c), thickening is visible in the

    gallbladder wall (arrow), along with a lare gallstone

    (arrowhead)

  • 7/29/2019 m89-Acute Calculous Chole Cystitis 1-2

    7/23

    Figure 2. Hepatobiliary Scintigraphy.

    InPanel A, a normal liver is visible 10 minutes after the intravenous injection of a technetium-labeled analogue of iminodiacetic acid.

    In Panel B, at 55 minutes after tracer injection, filling of the bile duct (arrow) and gallbladder (arrowhead) can be seen. In Panel C, at

    1 hour after tracer injection in a patient with acute cholecystitis and obstruction of the cystic duct, there is filling of the bile duct

    (arrow) but no filling of the gallbladder.

    Figure 2. Hepatobiliary Scintigraphy.

    InPanel A, a normal liver is visible 10 minutes after the intravenous injection of a technetium-labeled analogue of iminodiacetic acid.

    In Panel B, at 55 minutes after tracer injection, filling of the bile duct (arrow) and gallbladder (arrowhead) can be seen. In Panel C, at

    1 hour after tracer injection in a patient with acute cholecystitis and obstruction of the cystic duct, there is filling of the bile duct(arrow) but no filling of the gallbladder.

  • 7/29/2019 m89-Acute Calculous Chole Cystitis 1-2

    8/23

    Local symptoms and signsMurphy's sign

    Pain or tenderness in RUQ

    Mass in RUQ

    Systemic signsFever

    Leucocytosis

    Elevated CRP

    Imaging findingsA confirmatory finding on US or HB scintography

    Presence of one local signs or symptoms

    One systemic sign, and

    A confirmatory finding on an imaging test

  • 7/29/2019 m89-Acute Calculous Chole Cystitis 1-2

    9/23

    acute cholecystitis not meeting criteria for a more severe grade

    Mild gallbladder inflammation, no organ dysfunction

    presence of one or more of following:

    WBC>18000

    Palpable, tender mass in RUQ

    Duration > 72h

    Marked local in tlammarion: biliary peritonitis, pericholecystic abscess, hepatic

    abscess, gangrenous cholecystitis, emphysematous cholecystitis

    presence of one or more of following: CVS dysfunction ( BP requiring dopamine at 5 microgr/kg/min or any dose of Dobutamine)

    CNS dysfunction ( level of consciousness)

    Respiratory dysfunction (ratio of pO2 of arterial blood to the fraction of inspired oxygen 2mg/dL) Hepatic dysfunction (PT INR >1.5)

    Hematologic dysfunction (platelet

  • 7/29/2019 m89-Acute Calculous Chole Cystitis 1-2

    10/23

    Laparascopic VS open

    Early VS delayed

    From 24h to 7 days after initial attack

    2-3 months after afte initial attack

    Percutaneous

    Operative

  • 7/29/2019 m89-Acute Calculous Chole Cystitis 1-2

    11/23

  • 7/29/2019 m89-Acute Calculous Chole Cystitis 1-2

    12/23

  • 7/29/2019 m89-Acute Calculous Chole Cystitis 1-2

    13/23

  • 7/29/2019 m89-Acute Calculous Chole Cystitis 1-2

    14/23

  • 7/29/2019 m89-Acute Calculous Chole Cystitis 1-2

    15/23

    Fasting, obstruction, post surgical ileus, TPN

    Inspissated bile toxic to epithelium

  • 7/29/2019 m89-Acute Calculous Chole Cystitis 1-2

    16/23

    SurgeryRadiologyClinical findings

    Aspiration of GB/ drainageUSSetting (inpatient, out patient)

    LaparatomyCTFever, abdominal painHIDA SCANLeucocytosis, abnormal LFT

  • 7/29/2019 m89-Acute Calculous Chole Cystitis 1-2

    17/23

  • 7/29/2019 m89-Acute Calculous Chole Cystitis 1-2

    18/23

  • 7/29/2019 m89-Acute Calculous Chole Cystitis 1-2

    19/23

  • 7/29/2019 m89-Acute Calculous Chole Cystitis 1-2

    20/23

  • 7/29/2019 m89-Acute Calculous Chole Cystitis 1-2

    21/23

  • 7/29/2019 m89-Acute Calculous Chole Cystitis 1-2

    22/23

  • 7/29/2019 m89-Acute Calculous Chole Cystitis 1-2

    23/23

    Figure 1. (A and B) Longitudinal and horizontal sonogram of a 64-year-old man with positive

    Murphy sign, showing hydrops. (C) CT scan 6 hours later showing thickened GB wall

    (white arrow), hydrops, and pericholecystic inflammation (asterisk). Figure courtesy

    of Dr Shaile Choudhary, MD (Department of Radiology, University of Texas HealthScience at San Antonio, San Antonio, TX).